Will Cragg @willjcragg.bsky.social · 10/02/2025Regarding 'automatic' approval for low-risk trials - possible unintended consequences? Could it raise concerns about oversight and monitoring? Will there be appropriate scrutiny? 100
Will Cragg @willjcragg.bsky.social · 10/02/2025Speaker supports the transparency measures - registering trials and reporting all results. Still a need to handle confidential information properly (IP, participant data) - what safeguards will there be? 100
Will Cragg @willjcragg.bsky.social · 10/02/2025And might the rules have unintended consequences on trial designs? (I didn't totally follow this point) 100
